Teva Pharmaceutical Industries reported $195M in Interest Expense on Debt for its fiscal quarter ending in June of 2026.





Interest Expense On Debt Change Date
Aspen Pharmacare ZAR 631.5M 301.5M Jun/2024
Cipla INR 170.3M 39M Jun/2026
Dr.Reddys Laboratories INR 1.26B 198M Jun/2026
Guangzhou Baiy CNY 102.39M 780K Jun/2025
Jiangsu Hengrui CNY 254.59M 253.85M Sep/2025
Kalbe Farma IDR 9.69B 689.63M Sep/2025
Richter Gedeon HUF 7.5B 9.53B Sep/2024
Sh Fosun Pharma CNY 321.25M 2M Sep/2025
Sun Pharmaceuticals INR 859M 139.6M Mar/2026
Teva Pharmaceutical Industries USD 195M 21M Jun/2026